Trastuzumab combined with ramucirumab and paclitaxel in patients with previously treated human epidermal growth factor receptor 2–positive advanced gastric or gastroesophageal junction cancer
- J. Clin. Oncol., Published online June 26, 2023 | DOI: 10.1200/JCO.22.02122